Hearing Aids for Sensorineural Hearing Loss

NS
DL
Overseen ByDavid Landsberger, Ph.D.
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: NYU Langone Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to use an optimized version of the SEDA algorithm (SEDA-HA) for hearing aids to evaluate the benefit for listeners with varying degrees of hearing loss in realistic environments and evaluate its impact on speech perception and sound quality. The primary objective is to evaluate performance with and without the SEDA-HA algorithm on speech perception and speech reception tasks. The secondary objective is to evaluate performance of and experience with SEDA-HA integrated into a portable hearing aid prototype in the laboratory and in real-world situations outside the laboratory.

Who Is on the Research Team?

DL

David Landsberger, Ph.D.

Principal Investigator

NYU Langone Health

Are You a Good Fit for This Trial?

This trial is for people with temporary or sensorineural hearing loss. Participants should be able to use a hearing aid and take part in listening tests both in the lab and real-world settings.

Inclusion Criteria

Be willing and able to provide consent
I am 16 years old or older.
I have hearing loss in both ears confirmed by specific hearing tests.
See 1 more

Exclusion Criteria

I have conductive or mixed hearing loss based on my hearing tests.
I am younger than 16 years old.

What Are the Treatments Tested in This Trial?

Trial Overview

The study is testing a new speech enhancement algorithm (SEDA-HA) built into a prototype hearing aid. It compares how well users understand speech and perceive sound quality with and without this technology, both indoors and outdoors.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Group I: Severe hearing lossExperimental Treatment2 Interventions
Group II: Moderate hearing lossExperimental Treatment2 Interventions
Group III: Mild hearing lossExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator

Trials
377
Recruited
190,000+